Snowball logo
logo
APUS

Apimeds Pharmaceuticals US, Inc.

APUS NYSE MKT
$1.77+$0.10  (5.99%)
Estimate
EPS
-35.98
Beta
0.178
Growth
Net income, YoY
-657.76%
FCF, YoY
-65.72%
About the company
Ticker
APUS
ISIN
US03771D1028
Country
United States of America
Sector (GICS)
Financials
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Frequently asked questions

What sector does Apimeds Pharmaceuticals US, Inc. (APUS) operate in?

Apimeds Pharmaceuticals US, Inc. belongs to the Financials sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Apimeds Pharmaceuticals US, Inc. (APUS) current stock price?

As of the latest data, Apimeds Pharmaceuticals US, Inc. stock price is $1.77, with a previous close of $1.67. Apimeds Pharmaceuticals US, Inc. gained $0.10 in the last trading session, representing a 5.99% increase.

What is Apimeds Pharmaceuticals US, Inc. (APUS) current market capitalization?

Apimeds Pharmaceuticals US, Inc. market cap is approximately 2.67 million.

What is Apimeds Pharmaceuticals US, Inc. (APUS) Earnings Per Share (EPS)?

The trailing EPS is -$35.98.

What is Apimeds Pharmaceuticals US, Inc. (APUS) EBITDA?

Apimeds Pharmaceuticals US, Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -16.93 million.

Does Apimeds Pharmaceuticals US, Inc. (APUS) pay dividends?

No. Apimeds Pharmaceuticals US, Inc. does not pay a dividend.

What is Apimeds Pharmaceuticals US, Inc. (APUS) beta (volatility) score?

Apimeds Pharmaceuticals US, Inc. has a beta of 0.178, indicating lower volatility than the overall market.